| SHY | VGSH | SHY / VGSH | |
| Gain YTD | 0.611 | 0.670 | 91% |
| Net Assets | 25.4B | 33.8B | 75% |
| Total Expense Ratio | 0.15 | 0.03 | 500% |
| Turnover | 57.00 | 93.00 | 61% |
| Yield | 3.68 | 3.87 | 95% |
| Fund Existence | 24 years | 17 years | - |
| SHY | VGSH | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 10% | 2 days ago 10% |
| Momentum ODDS (%) | 2 days ago 5% | 2 days ago 6% |
| MACD ODDS (%) | 2 days ago 4% | 2 days ago 4% |
| TrendWeek ODDS (%) | 2 days ago 9% | 2 days ago 10% |
| TrendMonth ODDS (%) | 2 days ago 13% | 2 days ago 13% |
| Advances ODDS (%) | 29 days ago 10% | 29 days ago 9% |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 24 days ago 6% | 24 days ago 7% |
| Aroon ODDS (%) | 2 days ago 20% | 2 days ago 20% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 102.92 | N/A | N/A |
| ProShares Ultra Nasdaq Biotechnology | |||
| SEEM | 39.07 | N/A | N/A |
| SEI Select Emerging Markets Equity ETF | |||
| TOTL | 38.72 | -0.10 | -0.26% |
| State Street® DoubleLine® TR Tact ETF | |||
| TEQI | 50.98 | -0.52 | -1.00% |
| T. Rowe Price Equity Income ETF | |||
| DTAN | 31.44 | -0.36 | -1.12% |
| Sparkline International IntangibleValETF | |||